Download the report by clicking the link at the top right or bottom right of the page.
The debate over the trough that defined Q3 was effectively settled by Q4 earnings. Across diversified chemicals, chlor-alkali, and acetyl value chains, cautious results and muted 2026 guidance reinforced what the data had been signaling for several quarters: while the cyclical component is real, the depth and duration of this downturn increasingly reflects structural characteristics rather than a transient soft patch. The destocking cycle is behind us. What remains is a demand environment that is weaker than the pre-2022 baseline, compounded by structural oversupply across key value chains; the result of a substantial capacity buildout in China that continues to add supply into a domestic demand environment that has not developed as anticipated. The combination of softer end markets and a supply base that the industry has not yet fully absorbed means that earnings recovery is now broadly viewed as a mid-to-late 2026 story at the earliest.
